gepirone has been researched along with Depressive Disorder in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feiger, AD; Gibertini, M; Heiser, JF; Shrivastava, RK; Sitsen, JM; Smith, WT; Weiss, KJ | 1 |
| Gibertini, M; Robinson, DS; Sitsen, JM | 1 |
| Alpert, JE; Fava, M; Franznick, DA; Hollander, SB | 1 |
| Archibald, DG; Jenkins, SW; McGrath, PJ; Quitkin, FM; Robinson, DS; Stewart, JW; Stringfellow, JC; Wager, S | 1 |
| Dale, JL; Ferguson, JM; Heiser, JF; Wilcox, CS | 1 |
| Feiger, AD | 1 |
| Amsterdam, JD | 1 |
| Stahl, SM | 1 |
| Hauger, RL; Rausch, JL; Stahl, SM | 1 |
| Copp, JE; Robinson, DS; Schwiderski, UE | 1 |
| Andary, JJ; Fabre, LF; Jenkins, SW; Messina, ME; Reich, LA; Robinson, DS | 1 |
| Moeller, FG; Rausch, JL; Ruegg, R | 1 |
| Alms, DR; Messina, M; Robinson, DS; Shrotriya, RC; Wickramaratne, P | 1 |
1 review(s) available for gepirone and Depressive Disorder
| Article | Year |
|---|---|
A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone.
Topics: Antidepressive Agents; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 2003 |
10 trial(s) available for gepirone and Depressive Disorder
| Article | Year |
|---|---|
Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Humans; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Pyrimidines; Serotonin Receptor Agonists; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2003 |
Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Delayed-Action Preparations; Depressive Disorder; Dizziness; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Pyrimidines; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome | 2004 |
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Pyrimidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1994 |
A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyrimidines | 1996 |
A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
Topics: Adult; Antidepressive Agents; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines | 1996 |
Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Brain; Clinical Trials as Topic; Depressive Disorder; Female; Growth Hormone; Humans; Hydrocortisone; Male; Middle Aged; Pyrimidines; Receptors, Serotonin; Single-Blind Method | 1990 |
Symptom comorbidity in anxiety and depressive disorders.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Panic; Personality Assessment; Piperazines; Psychometrics; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles | 1990 |
Gepirone in the treatment of major depression.
Topics: Adult; Aged; Anti-Anxiety Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Randomized Controlled Trials as Topic | 1990 |
Gepirone as a 5-HT1A agonist in the treatment of major depression.
Topics: Adult; Aged; Anti-Anxiety Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Serotonin | 1990 |
Serotonergic anxiolytics and treatment of depression.
Topics: Adult; Brain; Buspirone; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Psychological Tests; Pyrimidines; Random Allocation; Receptors, Serotonin | 1989 |
2 other study(ies) available for gepirone and Depressive Disorder
| Article | Year |
|---|---|
Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression.
Topics: Adult; Anti-Anxiety Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pyrimidines; Serotonin | 1992 |
Neuroendocrine markers of serotonin responsivity in depression.
Topics: Antidepressive Agents; Biomarkers; Depressive Disorder; Humans; Hydrocortisone; Neurosecretory Systems; Pyrimidines; Receptors, Serotonin; Serotonin | 1992 |